Your browser doesn't support javascript.
loading
Disulfiram repurposing combined with nutritional copper supplement as add-on to chemotherapy in recurrent glioblastoma (DIRECT): Study protocol for a randomized controlled trial.
Jakola, Asgeir Store; Werlenius, Katja; Mudaisi, Munila; Hylin, Sofia; Kinhult, Sara; Bartek, Jiri; Salvesen, Øyvind; Carlsen, Sven Magnus; Strandéus, Michael; Lindskog, Magnus; Löfgren, David; Rydenhag, Bertil; Carstam, Louise; Gulati, Sasha; Solheim, Ole; Bartek, Jiri; Solheim, Tora.
Afiliação
  • Jakola AS; Department of Neurosurgery, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Werlenius K; Department of Neurosurgery, St. Olavs Hospital, Trondheim, Norway.
  • Mudaisi M; Institute of Neuroscience and Physiology, Department of Clinical Neuroscience, University of Gothenburg, Sahlgrenska Academy, Gothenburg, Sweden.
  • Hylin S; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Kinhult S; Institute of Clinical Sciences, University of Gothenburg, Sahlgrenska Academy, Gothenburg, Sweden.
  • Bartek J; Department of Oncology, Linköping University Hospital, Linköping, Sweden.
  • Salvesen Ø; Department of Neurology, Karolinska University Hospital, Stockholm, Sweden.
  • Carlsen SM; Department of Oncology, Skåne University Hospital, Lund, Sweden.
  • Strandéus M; Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden.
  • Lindskog M; Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
  • Löfgren D; Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway.
  • Rydenhag B; Department of Cancer Research and Molecular medicine, Norwegian University of Science and Technology, Trondheim, Norway.
  • Carstam L; Department of Endocrinology, St. Olavs Hospital, Trondheim, Norway.
  • Gulati S; Department of Oncology, County Hospital Ryhov, Jönköping, Sweden.
  • Solheim O; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Bartek J; Section of Oncology, Akademiska University Hospital, Uppsala, Sweden.
  • Solheim T; Department of Oncology, Örebro University Hospital, Örebro, Sweden.
F1000Res ; 7: 1797, 2018.
Article em En | MEDLINE | ID: mdl-30647912
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Cobre / Suplementos Nutricionais / Dissulfiram / Reposicionamento de Medicamentos / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: F1000Res Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Suécia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Cobre / Suplementos Nutricionais / Dissulfiram / Reposicionamento de Medicamentos / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: F1000Res Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Suécia